Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities.
Franzese E, Falco S, Laterza MM, Montella L, Facchini S, Liguori C, Coppola P, Diessa Y, Berretta M, Pisconti S, Trama F, Ferro M, Crocetto F, Fasano M, Buonerba C, Facchini G. Franzese E, et al. Among authors: crocetto f. Future Sci OA. 2021 Apr 7;7(6):FSO705. doi: 10.2144/fsoa-2021-0035. Future Sci OA. 2021. PMID: 34046207 Free PMC article. No abstract available.
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Buonerba C, Dolce P, Iaccarino S, Scafuri L, Verde A, Costabile F, Pagliuca M, Morra R, Riccio V, Ribera D, De Placido P, Romeo V, Crocetto F, Longo N, Imbimbo C, De Placido S, Di Lorenzo G. Buonerba C, et al. Among authors: crocetto f. Cancers (Basel). 2020 Feb 10;12(2):408. doi: 10.3390/cancers12020408. Cancers (Basel). 2020. PMID: 32050629 Free PMC article. Review.
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.
Buonerba C, Ferro M, Dolce P, Crocetto F, Verde A, Lucarelli G, Scafuri L, Facchini S, Vaia A, Marinelli A, Terracciano D, Montella L, Longo N, Imbimbo C, Mirone V, Di Lorenzo G, De Placido S, Sonpavde G. Buonerba C, et al. Among authors: crocetto f. Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23. Crit Rev Oncol Hematol. 2020. PMID: 32474391
Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study.
Fusco F, Creta M, Trama F, Esposito F, Crocetto F, Aveta A, Mangiapia F, Imbimbo C, Capece M, La Rocca R, Mirone V, Longo N. Fusco F, et al. Among authors: crocetto f. Arch Ital Urol Androl. 2020 Oct 1;92(3). doi: 10.4081/aiua.2020.3.173. Arch Ital Urol Androl. 2020. PMID: 33016038 Free article.
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.
Ferro M, Lucarelli G, Crocetto F, Dolce P, Verde A, La Civita E, Zappavigna S, de Cobelli O, Di Lorenzo G, Facchini BA, Scafuri L, Onofrio L, Porreca A, Busetto GM, Sonpavde G, Caraglia M, Klain M, Terracciano D, De Placido S, Buonerba C. Ferro M, et al. Among authors: crocetto f. Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13. Crit Rev Oncol Hematol. 2021. PMID: 33316417
Focus on Silodosin: Pros and Cons of Uroselectivity.
Califano G, Collà Ruvolo C, Creta M, Capece M, La Rocca R, Celentano G, Napolitano L, Calace FP, Spena G, Trama F, Crocetto F, Mangiapia F, Longo N, Fusco F. Califano G, et al. Among authors: crocetto f. Res Rep Urol. 2020 Dec 23;12:669-672. doi: 10.2147/RRU.S287129. eCollection 2020. Res Rep Urol. 2020. PMID: 33381467 Free PMC article. Review.
175 results